openPR Logo
Press release

Considerable Improvement in Research and Development Efforts in the Industry Will Boost 3D Bioprinting Market

05-24-2017 03:25 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Considerable Improvement in Research and Development Efforts

Global 3D Bioprinting Market: Overview

Three-dimensional bioprinting refers to the process of developing cell patterns in a limited space with the help of 3D printing technologies. The viability and function of the cells are retained within the printed structure. Recent developments have made possible 3D printing of biocompatible cells and materials into three-dimensional, complex, and functional living tissues. The growing need for organs and tissues that are suitable for transplantation has fueled the application of 3D bioprinting in regenerative medicine.

Browse through 3D Bioprinting Market report to know what factors will shape the market by 2024: http://www.transparencymarketresearch.com/3d-bioprinting-market.html

Some of the leading industry technologies used in 3D bioprinting are inkjet-based printing, magnetic levitation, laser-based printing, and syringe-based printing. These technologies have expanded the application of 3D bioprinting in areas such as medical, bioinks, personal and consumer product testing, dental, biosensors, and food and animal product bioprinting.

The research report offers a detailed assessment of the global 3D bioprinting market. The strengths, weaknesses, opportunities, and threats to individual companies, regional segments, and the market as a whole have been elaborated to give clients a well-rounded overview of the structure, contribution, and performance of the 3D bioprinting market. The most prominent players, the dominant and struggling segments, and the future of the 3D bioprinting market have been analyzed in the research.

Global 3D Bioprinting Market: Key Trends and Opportunities

The global 3D bioprinting market has witnessed significant growth in the past few years. This is attributed to factors such as increase in lifespan of individuals, growing incidence of chronic illnesses, rise in demand for tissue and organ transplants, incorporation of IT within the health care sector, limited number of organ donors, rapid advancement in 3D printing technology, and growing geriatric population. In addition, considerable improvement in research and development efforts in the industry has boosted the 3D bioprinting market. The prospects of bioprinted organs, implants, and tissue reconstructions seem positive in the near future thanks to the efforts of research institutes and universities.

Growing use of 3D bioprinting technology in the medical sector is one of the major drivers of the global market. Apart from regeneration of tissues, organs, prosthetics, and implants, the production of 3D bioprinted pills presents lucrative options for players in the 3D bioprinting market. Escalating need for personalized medicine and cost-efficient and rapid production of biodrugs are likely to propel the market in the near future.

Global 3D Bioprinting Market: Region-wise Outlook and Vendor Landscape

Geographically, the global 3D bioprinting market comprises North America, Asia Pacific, Europe, and Rest of the World. North America is the largest market for 3D bioprinting in terms of revenue and is fueled by several macro and micro factors, including improved health care infrastructure, presence of a massive chronically ill and geriatric population, and high disposable income of the people. Continuous research activities in the field of 3D printing are boosting market growth in North America. The 3D bioprinting market in Asia Pacific is anticipated to emerge as a strong contender in the global scenario thanks to the rapid adoption and adaption of technological advancements, development of health care IT, supportive government initiatives, rising foreign investments, and growing awareness about the technology.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving 3D Bioprinting Market by 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11657

Leading players in the global 3D bioprinting market include Oceanz, Luxexcel Group BV, Organovo Holding, Inc., TeVido BioDevices, Voxeljet, Stratasys Ltd., Aspect Biosystems, Solidscape, Materialise NV, Cyfuse Biomedical, Bio3D Technologies, 3Dynamics Systems, Envision TEC, and BioBots. An increasing number of companies have been partnering with universities and research institutes that are dedicated toward working on organ regeneration technologies. Several seminars and exhibitions have also been held to raise awareness regarding the 3D bioprinting industry across the world.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Considerable Improvement in Research and Development Efforts in the Industry Will Boost 3D Bioprinting Market here

News-ID: 550042 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Bioprinting

3D Bioprinting Market Growth Probability, Leading Vendors and Future Scenario Du …
An influential 3D Bioprinting Market report is the most suitable solution for the business requirements in many ways. The report aids in achieving an extreme sense of evolving industry movements before the competitors. The report also covers market overview, premium insights, key insights and company profiles in detail of the key market players. The best tools have been adopted to generate this report which is SWOT analysis and Porter’s
3D Bioprinting Market: Future of Bioprinting, it is Creating Real Change in the …
The growth of the 3D bioprinting market is mainly driven by the technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities, especially in emerging markets, which are expected to witness the highest growth. The 3D
Current Bioprinting Prospects and Future Innovations
Bharat Book Bureau Provides the Trending Market Research Report on“Global Current Bioprinting Prospects and Future Innovations Market Forecast to 2019-2024”under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports. Report Scope: This new BCC Research report on the topic “Current Bioprinting Prospects and Future Innovations” offers a detailed perspective on bioprinting technology, its current market and future prospects. The report provides a
Bioprinting Global Market 2018: Key Players – 3D BIO CORP., 3D BIOPRINTING SOL …
Bioprinting Industry Description Wiseguyreports.Com Adds “Bioprinting -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database 3-D printers are beginning to revolutionize the manufacturing industry and are now increasingly used to make finished parts and goods. This industry is reshaping traditional supply chains and is enabling localization and customization in the manufacturing sector. Bioprinting is related to 3-D printing but uses living cells as well as
3D Bioprinting in Global Market 2017 - 2022
This report studies 3D Bioprinting in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Organovo Holdings Inc. EnvisionTEC GmbH Nano3D Biosciences, Inc. Cyfuse Biomedical K.K. BioBots Aspect Biosystems Ltd. 3Dynamic Systems Ltd. regenHU Ltd Cellink Browse complete report
3D Bioprinting market : Global Overview 2022
Research Trades adds a new report package “3D Bioprinting market- Size, Share, Trends, Forecast, Growth 2022” In this report, the global 3D Bioprinting market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market